<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01634477</url>
  </required_header>
  <id_info>
    <org_study_id>TNT-HIV 003</org_study_id>
    <nct_id>NCT01634477</nct_id>
  </id_info>
  <brief_title>Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study</brief_title>
  <acronym>TNT-HIV</acronym>
  <official_title>Trends of Morbidity and Mortality Among Thai HIV-infected and HIV-uninfected Patients: a Five-year Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thai Red Cross AIDS Research Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>HIV Netherlands Australia Thailand Research Collaboration</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bamrasnaradura Infectious Diseases Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Queen Savang Vadhana Memorial Hospital, Thailand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Thai Red Cross AIDS Research Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To describe the morbidity and clinical characteristics among HIV-infected patients and
           HIV-uninfected patients.

        2. To identify the risk factors for the complication or morbidity among HIV-infected
           patients and HIV-uninfected patients.

        3. To describe the mortality among HIV-infected patients and HIV-uninfected patients.

        4. To identify the risk factors for the cause of death among HIV-infected and
           HIV-uninfected patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The information obtained from this study would be very important in planning future holistic
      care of HIV-infected patients in our institutes as well as in national policy. Results from
      the study could be used to develop proper long-term management guidelines for people living
      with HIV (PLHIV) in Thailand targeted at preventable conditions such as metabolic diseases
      and certain cancers.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>morbidity</measure>
    <time_frame>60 months</time_frame>
    <description>development of other diseases</description>
  </primary_outcome>
  <primary_outcome>
    <measure>HIV related illness</measure>
    <time_frame>60 months</time_frame>
    <description>development of opportunistic infection such as Non-Hodkin's lymphoma, Kaposi's sarcoma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Non HIV-related illness</measure>
    <time_frame>60 months</time_frame>
    <description>development of Dyslipidemia, Hypertension, DM, CVD , Cancer, osteopenia, osteoporosis, Renal disease, liver disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>60 months</time_frame>
    <description>death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>CVD</measure>
    <time_frame>60 months</time_frame>
    <description>development of CVD</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">816</enrollment>
  <condition>HIV Infection</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>HIV-infected patients group</arm_group_label>
    <description>HIV positive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV-uninfected patients group</arm_group_label>
    <description>HIV negative</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Thai HIV-infected patients with and without ART, and HIV negative patients from the Thai
        Red Cross AIDS Research Centre and Queen Savang Memorial Hospital Institute during January
        2010 - December 2014
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        HIV-infected patients group

          -  HIV positive

          -  30 years of age or older, both male and female

          -  Thai nationality

          -  Written research informed consent

        HIV-uninfected patients group

          -  HIV un-infected

          -  30 years of age or older, both male and female

          -  Thai nationality

          -  Written research informed consent

        Exclusion Criteria:

        HIV-infected patients group

          -  Systolic BP ≥ 130 or Diastolic BP ≥ 85mm Hg or on the treatment

          -  Fasting blood sugar &gt; 126 mg/dl or on the treatment

          -  Proteinuria

          -  Creatinine &gt; 1.5 mg/dl

          -  Recent hospitalization

          -  Patient who are having mental disease HIV-uninfected patients group

          -  Systolic BP ≥ 130 or Diastolic BP ≥ 85mm Hg or on the treatment

          -  Fasting blood sugar &gt; 126 mg/dl or on the treatment

          -  Proteinuria

          -  Creatinine &gt; 1.5 mg/dl

          -  Recent hospitalization

          -  Patient who are having mental disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Praphan Phanuphak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Thai Red Cross AIDS Research Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Thai Red Cross AIDS Research Centre</name>
      <address>
        <city>Pathum Wan</city>
        <state>Bangkok</state>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2012</study_first_submitted>
  <study_first_submitted_qc>July 5, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2012</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>morbidity</keyword>
  <keyword>mortality</keyword>
  <keyword>HIV-infected patients</keyword>
  <keyword>prospective cohort study</keyword>
  <keyword>highly active antiretroviral therapy (HAART)</keyword>
  <keyword>opportunistic infections</keyword>
  <keyword>Non HIV-related illness</keyword>
  <keyword>cardiovascular disease (CVD)</keyword>
  <keyword>HIV negative patients</keyword>
  <keyword>Thai HIV-infected patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

